Lumenis ophthalmic unit has been streamlined to report to Gideon Sturlesi, who will lead the unit for the present time in addition to his role as Lumenis’s corporate vice president for business development. He will replace Jake Zanden, senior vice president and general manager of Lumenis ophthalmic strategic business unit who is leaving the company.
Mr Sturlesi is a seasoned executive with experience in heading successful turnarounds with proven hands on management experience. Prior to joining Lumenis, Mr Sturlesi served as co-founder of Galil Medical and as CEO of its US activity, and was the founder and general partner of BioMedical Israel.
Mr Sturlesi holds a BSc and MSc (cum-laude) from the Technion – Israel Institute of Technology and holds patents and has released publications in medical device technology.